Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Discovery of novel thiazolidinedione derivatives that inhibit HBV internalization

Oct. 6, 2021

SARS-CoV-2 virus-specific T-cell therapy may be effective against variants

Oct. 6, 2021

KRP-A218, an oral PI4KB inhibitor, is a potent antiviral in vivo

Oct. 5, 2021

JSF-3151 demonstrates efficacy in mouse model of MRSA infection

Oct. 5, 2021

Microbiome therapy SER-155 may restore colonization resistance and prevent infection

Oct. 5, 2021

Identification of novel viral cleavage sites and potential therapeutic targets against SARS-CoV-2

Oct. 1, 2021

New antivirals presented by EcoSynth, Transmare Chemie

Oct. 1, 2021

Aston University descibres new antibacterials

Oct. 1, 2021

VBI reports new preclinical data on COVID-19 vaccine candidates VBI-2902, VBI-2905 and VBI-2901

Sep. 30, 2021

CD147 as therapeutic target against SARS-CoV-2 and its variants

Sep. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...